Czechia, Jan. 13 -- Czechia based AbbVie s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Supplies of the drug - RINVOQ 2025. The value of the contract is worth 9182300000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....